S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

$0.26
-0.01 (-3.65%)
(As of 03/28/2024 ET)
Today's Range
$0.26
$0.29
50-Day Range
$0.20
$0.38
52-Week Range
$0.20
$0.55
Volume
369,441 shs
Average Volume
514,478 shs
Market Capitalization
$99.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MRMD stock logo

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

MRMD Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
MariMed's Earnings: A Preview
MariMed Closes $58.7 Million Debt Refinancing
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
643
Year Founded
N/A

Profitability

Net Income
$-16,030,000.00
Pretax Margin
-4.44%

Debt

Sales & Book Value

Annual Sales
$148.60 million
Cash Flow
$0.03 per share
Book Value
$0.19 per share

Miscellaneous

Free Float
298,041,000
Market Cap
$102.22 million
Optionable
Not Optionable
Beta
2.85
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Jon R. Levine (Age 59)
    Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
    Comp: $481.74k
  • Mr. Timothy Shaw (Age 46)
    Chief Operating Officer
    Comp: $445.86k
  • Mr. Jonathan W. Rider (Age 59)
    Chief Information Officer
  • Mr. Steve Wayne West
    Vice President of Investor Relations
  • Mr. Howard Schacter
    Chief Communications Officer
  • Ms. Sara Gullickson (Age 39)
    Vice President of Marketing
  • Mr. Ryan Crandall
    Chief Revenue Officer
  • Mr. Charles Holt Finnie
    Chief Strategy Officer

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD shares have decreased by 3.9% and is now trading at $0.2641.
View the best growth stocks for 2024 here
.

Are investors shorting MariMed?

MariMed saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 53,200 shares, an increase of 198.9% from the February 29th total of 17,800 shares. Based on an average daily volume of 1,346,700 shares, the short-interest ratio is presently 0.0 days.
View MariMed's Short Interest
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) released its quarterly earnings results on Monday, November, 15th. The company reported $0.01 EPS for the quarter. The business had revenue of $33.21 million for the quarter. MariMed had a negative trailing twelve-month return on equity of 1.84% and a negative net margin of 10.79%.

What guidance has MariMed issued on next quarter's earnings?

MariMed issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?
How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners